TrialRheumatology international2025

RhePort 1.3 enhances early identification of inflammatory rheumatic diseases: a prospective study in German rheumatology settings.

Cay-Benedict von der Decken et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.